Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self
The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Abstract
Naturally arising CD25(+)CD4(+) regulatory T cells actively maintain immunological self-tolerance. Deficiency in or dysfunction of these cells can be a cause of autoimmune disease. A reduction in their number or function can also elicit tumor immunity, whereas their antigen-specific population expansion can establish transplantation tolerance. They are therefore a good target for designing ways to induce or abrogate immunological tolerance to self and non-self antigens.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Growing evidence has shown that Treg cells are recruited into the TME and behave as powerful immunosuppressors.61, 62”
From Reactive Oxygen Species in Cancer: Current Findings and Future Directions (2021) · cites this paper as [62]
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Self-citationFoxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745 · cited 1×
“In addition, they specifically express Foxp3 , which encodes a transcription factor, as a key control gene in their development and functio”
BackgroundPark, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Self-citationA CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., & Roncarolo, M. G. (1997) · Nature · doi:10.1038/39614 · Cited by 3,588
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Sakaguchi, S. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141122 · Cited by 3,306
Self-citationThe Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032 · cited 1×
“The fact that many tumor-associated antigens recognized by autologous T cells in cancer patients are antigenically normal self constituents indicates that natural CD25 + CD4 + T reg cells engaged in the maintenance of self-tolerance may concomitantly impede immunosurveillance against autologous tumor cell”
BackgroundTivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
Research works printed but not linked: 1
- Setoguchi, R., Hori, S., Takahashi, T. & Sakaguchi, S. A crucial role of IL-2 in the homeostatic maintenance of CD25+CD4+ regulatory T cells: induction of autoimmune disease by neutralization of IL-2. J. Exp. Med. (in the press).
Cited by
Items 501–600 of 1,010
Azab, N. A., Bassyouni, I. H., Emad, Y., El-Wahab, G. A. A., Hamdy, G., & Mashahit, M. A. (2008) · Clinical Immunology · doi:10.1016/j.clim.2007.12.010 · Cited by 105
Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis
Marín, N. D., París, S. C., Marín, V. M. V., Rojas, C. A., Rojas, M., & García, L. F. (2010) · Tuberculosis · doi:10.1016/j.tube.2010.05.003 · Cited by 109
Bharat, A., Fields, R. C., Steward, N. S., Trulock, E. P., Patterson, G. A., & Mohanakumar, T. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01383.x · Cited by 101
“There was a predominance of IL-10 producing T cells (TIL−10) reactive to col-V with significantly lower levels of IFN-c and IL-2 producing T cells (Th1 cells).”
BackgroundInfluentialPathological conversion of regulatory T cells is associated with loss of allotolerance
Hua, J., Inomata, T., Chen, Y., Foulsham, W., STEVENSON, W. C., Shiang, T., Bluestone, J. A., & Dana, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-25384-x · Cited by 111
Terme, M., Chaput, N., Combadière, B., Ma, A. I., Ohteki, T., & Zitvogel, L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4679 · Cited by 109
IL-5 promotes induction of antigen-specific CD4+CD25+ T regulatory cells that suppress autoimmunity
Tran, G. T., Hodgkinson, S. J., Carter, N. M., Verma, N. D., Plain, K. M., Boyd, R. A., Robinson, C. M., Nomura, M., Killingsworth, M. C., & Hall, B. M. (2012) · Blood · doi:10.1182/blood-2011-12-396101 · Cited by 108
Changes in immune regulation in response to examination stress in atopic and healthy individuals
Höglund, C. O., Axén, J., Kemi, C., Jernelöv, S., Grunewald, J., Müller‐Suur, C., Smith, Y., Grönneberg, R., Eklund, A., Stierna, P., et al. (2006) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2006.02529.x · Cited by 98
The Dendritic Cell-Regulatory T Lymphocyte Crosstalk Contributes to Tumor-Induced Tolerance
Janikashvili, N., Bonnotte, B., Katsanis, E., & Larmonier, N. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/430394 · Cited by 103
“These cells constitute about 10% of the circulating T-lymphocyte population in mice and 5% in healthy humans [111].”
BackgroundRegulatory T Cells in Radiotherapeutic Responses
Schaue, D., Xie, M. W., Ratikan, J. A., & McBride, W. H. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00090 · Cited by 103
“…control of inflammatory responses at normal mucosal surfaces while nTregs appear more important for mediating self-tolerance and tumor immune escape (Sakaguchi, 2004, 2005; Curotto de Lafaille and Lafaille, 2009; Haribhai et al., 2011; Rosenblum et al., 2011; Josefowicz et al., 2012; Figure 1).”
BackgroundPhotosensitivity in lupus erythematosus
Kuhn, A., & Beissert, S. (2005) · Autoimmunity · doi:10.1080/08916930500285626 · Cited by 106
“In humans, naturally occurring CD4þCD25þ regulatory T cells with suppressor function have also been isolated and these cells appear to play an increasingly important role in inhibiting the development of autoimmune responses [109].”
BackgroundGasparoto, T. H., Malaspina, T. S. D. S., Benevides, L., de Melo, E. J. F., Nogueira, M. R. S., Damante, J. H., Ikoma, M. R. V., Garlet, G. P., Cavassani, K. A., Silva, J. S., et al. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0803-7 · Cited by 98
“Although the mechanism of action is not completely understood, these cells regulate CD4 and CD8 T cells, NK, dendritic cell, and macrophage [1, 2] activity during immune responses against pathogens, self-antigens, and tumors [ 3 , 4]. The involvement of Tregs in tumor progression has been extensively investigated [5]…”
BackgroundMoreli, J. B., Ruocco, A. M. C., Vernini, J. M., Rudge, M. V. C., & Calderon, I. D. M. P. (2012) · ISRN Obstetrics and Gynecology · doi:10.5402/2012/230742 · Cited by 98
“[25] S.”
BackgroundTGF-beta as a T cell regulator in colitis and colon cancer
Becker, C., Fantini, M. C., & Neurath, M. F. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.004 · Cited by 114
Regulatory T Cells and Transplantation Tolerance
Jiang, S., Lechler, R. I., He, X.-S., & Huang, J.-F. (2006) · Human Immunology · doi:10.1016/j.humimm.2006.07.013 · Cited by 106
Ramos, R. N., Chin, L. S., dos Santos, A. P. S. D. A., Bergami-Santos, P. C., Laginha, F. M., & Barbuto, J. A. M. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0112048 · Cited by 104
“[18] and play a relevant role in immune responses to infec-”
BackgroundBayry, J., Triebel, F., Kaveri, S. V., & Tough, D. F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4184 · Cited by 91
Novel mechanism of synergistic effects of conventional chemotherapy and immune therapy of cancer
Ramakrishnan, R., & Gabrilovich, D. I. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1390-6 · Cited by 103
Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia
Visser, J., Nijman, H. W., Hoogenboom, B.-N., Jager, P. O. J., van Baarle, D., Schuuring, E. M. D., Abdulahad, W. H., Miedema, F. F., van der Zee, A. G. J., & Daemen, T. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03468.x · Cited by 96
Stored Red Blood Cell Transfusion Induces Regulatory T Cells
Baumgartner, J. M., Silliman, C. C., Moore, E. E., Banerjee, A. M., & McCarter, M. D. (2008) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2008.08.012 · Cited by 96
Cao, Z., Wara, A. K., Icli, B., Sun, X., Packard, R. R. S., Esen, F., Stapleton, C. J., Subramaniam, M., Kretschmer, K., Apostolou, I., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.000059 · Cited by 97
Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer
Ohara, M., Yamaguchi, Y., Matsuura, K., Murakami, S., Arihiro, K., & Okada, M. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0570-x · Cited by 97
“Regulatory T (Treg) cells have been highlighted in tumor immunology [1, 2].”
BackgroundCao, X., Leonard, K., Collins, L. I., Cai, S. F., Mayer, J. C., Payton, J. E., Walter, M. J., Piwnica-Worms, D. R., Schreiber, R. D., & Ley, T. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1145 · Cited by 96
“IL-2 has been shown to be essential for Treg homeostasis and function (15, 29, 30); as expected, IL-2 receptor α (CD25) is upregulated in tumor-associated Treg cells.”
BackgroundButti, E., Bergami, A., Recchia, A., Brambilla, E., Carro, U. D., Amadio, S., Cattalini, A., Esposito, M., Stornaiuolo, A., Comı, G., et al. (2008) · Gene Therapy · doi:10.1038/gt.2008.10 · Cited by 97
Tumor Promotion by Tumor-Associated Macrophages
Porta, C., Kumar, B. S., Larghi, P., Rubino, L., Mancino, A., & Sica, A. (2007) · Advances In Experimental Medicine And Biology · doi:10.1007/978-0-387-69116-9_5 · Cited by 95
“Suppression of T-cell mediated antitumor activity by Treg cells is associated with increased tumor growth and, hence, decreased survival ( Sakaguchi 2005 ).”
BackgroundThe liver works as a school to educate regulatory immune cells
Li, F., & Tian, Z. (2013) · Cellular and Molecular Immunology · doi:10.1038/cmi.2013.7 · Cited by 96
Sato, N., Kinbara, M., Kuroishi, T., Kimura, K., Iwakura, Y., Ohtsu, H., Sugawara, S., & Endo, Y. (2007) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2007.02705.x · Cited by 95
Erythropoietin: A Potent Inducer of Peripheral Immuno/Inflammatory Modulation in Autoimmune EAE
Yuan, R., Maeda, Y., Li, W., Lu, W., Cook, S., & Dowling, P. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001924 · Cited by 94
“Antiinflammatory regulatory T cells have been found to be an important CD4 cell subpopulation for controlling the development of autoimmune disease [12,34,35,36,37,38].”
BackgroundEffects of Natalizumab on Circulating B Cells, T Regulatory Cells and Natural Killer Cells
Putzki, N., Baranwal, M., Tettenborn, B., Limmroth, V., & Kreuzfelder, E. (2010) · European Neurology · doi:10.1159/000302687 · Cited by 94
“Natural CD4+CD25+ regulatory T cells (Tregs) are of major importance to the maintenance of immunosurveillance and the control of autoimmunity and infectious disorders [ ,”
BackgroundSalemi, S., Diamanti, A. P., Germano, V., Donatelli, I., Martino, A. D., Facchini, M., Nisini, R., Biselli, R., Ferlito, C., Podestà, E., et al. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.09.014 · Cited by 94
Santodomingo-Garzon, T., Han, J., Le, T., Yang, Y., & Swain, M. G. (2009) · Hepatology · doi:10.1002/hep.22761 · Cited by 91
Saitoh, O., & Nagayama, Y. (2006) · Endocrinology · doi:10.1210/en.2005-1024 · Cited by 94
“2420 Endocrinology, May 2006, 147(5):2417–2422 Saitoh and Nagayama • CD4 CD25 T Cell in Mouse Graves’ Disease”
InfluentialParaneoplastic diseases associated with thymoma
Evoli, A., Minicuci, G. M., Vitaliani, R., Battaglia, A., Marca, G. D., Lauriola, L., & Fattorossi, A. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0429-z · Cited by 94
“Moreover, the identification of CD4SPCD25 as Treg cells (and their distinction from activated T cells) should include the assessment of the intracellular expression of the transcription factor FOXP3, currently considered as the most specific marker for human Treg cells [29].”
BackgroundLuther, C., Adamopoulou, E., Stoeckle, C., Brucklacher-Waldert, V., Rosenkranz, D., Stoltze, L., Lauer, S., Poeschel, S., Melms, A., & Tolosa, E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802046 · Cited by 93
“Thus, autoreactivity is an intrinsic feature of T cells and active suppression is required to maintain tolerance to self (2).”
BackgroundLi, Z., Mou, W., Lu, G., Cao, J., He, X.-P., Pan, X.-Y., & Xu, K. (2010) · International Journal of Hematology · doi:10.1007/s12185-010-0753-z · Cited by 93
“A subset of relatively rare T lymphocytes called T regulatory lymphocytes (Treg cells) play an important role in maintaining peripheral tolerance, which account for approximately 5‐10% of the normal CD4? T cell population [ 4 ].”
BackgroundSchildknecht, A., Brauer, S., Brenner, C., Lahl, K., Schild, H., Sparwasser, T., Probst, H. C., & van den Broek, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910620107 · Cited by 93
“CD4CD25FoxP3 Treg cells, first characterized by their immunosuppressive properties (5, 6), comprise ≈10–15% of all peripheralCD4Tcells inmice.”
BackgroundKawashiri, S., Kawakami, A., Okada, A., Koga, T., Tamai, M., Yamasaki, S., Nakamura, H., Origuchi, T., Ida, H., & Eguchi, K. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.110283 · Cited by 93
“Patients were divided into 3 groups: (1) those naive to disease-modifying antirheumatic drugs (DMARD; n = 13); (2) those with active RA (n = 19) whose disease activity was moderate (DAS28 > 3.”
MethodAltered homeostasis of CD4+ FoxP3+regulatory T‐cell subpopulations in systemic lupus erythematosus
Suen, J., Li, H., Jong, Y., Chiang, B., & Yen, J. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02937.x · Cited by 94
Chen, X.-H., Ruan, C.-C., Ge, Q., Ma, Y., Xu, J.-Z., Zhang, Z.-B., Lin, J.-R., Chen, D.-R., Zhu, D.-L., & Gao, P.-J. (2018) · Circulation Research · doi:10.1161/circresaha.117.312153 · Cited by 92
Hsiao, Y.-W., Liao, K., Chung, T.-F., Ch, L., Hsu, C.-D., & Chu, R. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0446-5 · Cited by 102
“Regulatory T cell is an important cell type in regulating immune homeostasis [37].”
BackgroundC-Phycocyanin is neuroprotective against global cerebral ischemia/reperfusion injury in gerbils
Pentón‐Rol, G., Marín‐Prida, J., Andreu, G. L. P., Martínez-Sánchez, G., Acosta-Medina, E. F., Valdivia, A., Lagumersindez-Denis, N., Jiménez, E. R., Llopiz, A., López-Saura, P. A., et al. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.05.016 · Cited by 101
“[98] S.”
BackgroundTuve, S., Chen, B., Liu, Y., Cheng, T., Touré, P. S., Sow, P. S., Feng, Q., Kiviat, N., Strauss, R., Ni, S., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4296 · Cited by 99
Fujimura, T., Okuyama, R., Ito, Y., & Aiba, S. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08504.x · Cited by 93
Biased signaling pathways via CXCR3 control the development and function of CD4+ T cell subsets
Karin, N., Wildbaum, G., & Thelen, M. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.2mr0915-441r · Cited by 89
“These cells suppress the activities of effector T cells and of inflammatory macrophages by various mechanisms, thus maintaining selftolerance [74–77].”
BackgroundSela, U., Olds, P., Park, A., Schlesinger, S. J., & Steinman, R. M. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110466 · Cited by 96
“Vol. 208 No. 12 2489-2496 www.jem.org/cgi/doi/10.1084/jem.20110466 2489 Regulatory T cells (T reg cells) that express the Foxp3 transcription factor and suppress immunity are generated in the thymus and are called nT reg cells (Marie et al., 2005; Sakaguchi, 2005).”
BackgroundInfluentialde Boer, O. J., van der Loos, C. M., Teeling, P., van der Wal, A. C., & Teunissen, M. B. M. (2007) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.6a7119.2007 · Cited by 91
Koh, J., Hur, J. Y., Lee, K. Y., Kim, M. S., Heo, J. Y., Ku, B. M., Sun, J.-M., Lee, S.-H., Ahn, J. S., Park, K., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-76130-1 · Cited by 87
The characterization and role of regulatory T cells in immune reactions
Jacek, R. W. (2007) · Frontiers in bioscience · doi:10.2741/2840 · Cited by 92
“It was shown that Foxp3-knockout mice displayed severe Treg deficiency and predisposition to autoimmune disorders and that due to mutations of human Foxp3 gene lethal autoimmune IPEX syndrome (X-linked immunodysregulation, polyendocrinopathy, enteropathy) developed (23).”
BackgroundGuilliams, M., Oldenhove, G., Noël, W., Hérin, M., Brys, L., Loi, P., Flamand, V., Moser, M., BAETSELIER, P. D., & Beschin, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2748 · Cited by 96
“In normal conditions, naturally occurring CD4 CD25 Foxp3 Tregs play an essential role in avoiding autoimmunity through inhibition of autoreactive T cells and maintenance of peripheral self-tolerance (3).”
BackgroundRegulatory T cells and viral liver disease
Alatrakchi, N., & Koziel, M. J. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01081.x · Cited by 91
Immunogenicity and immunomodulatory properties of HPMA-based polymers☆
Říhová, B., & Kovář, M. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.10.005 · Cited by 92
STAT3 in immune responses and inflammatory bowel diseases
Fu, X. Y. (2006) · Cell Research · doi:10.1038/sj.cr.7310029 · Cited by 95
Chen, Y., Jeffery, H. C., Hunter, S., Bhogal, R., Birtwistle, J., Braitch, M. K., Roberts, S., Ming, M., Hannah, J., Thomas, C., et al. (2016) · Hepatology · doi:10.1002/hep.28517 · Cited by 86
“(9,10) Treg are highly sensitive to CD95-mediated apoptosis,((11)) and interleukin (IL)-2-dependent phosphorylation of STAT5 is crucial for their proliferation, differentiation, and survival.((12)) We reported previously that many intrahepatic Treg lack evidence of STAT5 phosphorylation, suggesting that the inflammato…”
BackgroundZhang, T., Fresnay, S., Welty, E. E., Sangrampurkar, N., Rybak, E., Zhou, H., Cheng, X., Feng, Q., Avon, C., Laaris, A., et al. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03624.x · Cited by 91
“Foxp3 is a transcription factor important in the development and function of murine CD4+CD25+ Tregs (53).”
BackgroundKorporal, M., Haas, J., Balint, B., Fritzsching, B., Schwarz, A., Moeller, S., Fritz, B., Suri‐Payer, E., & Wildemann, B. (2008) · Archives of Neurology · doi:10.1001/archneur.65.11.1434 · Cited by 90
Mason, G. M., Jackson, S. E., Okecha, G., Poole, E. L., Sissons, J. G. P., Sinclair, J. H., & Wills, M. R. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003635 · Cited by 89
Shalev, I., Wong, K. M., Foerster, K., Zhu, Y. X., Chan, C., Maknojia, A., Zhang, J., Ma, X., Yang, X. C., Gao, J. F., et al. (2008) · Hepatology · doi:10.1002/hep.22684 · Cited by 89
Ernst, C. W. O., Lee, J. E., Nakanishi, T., Karimbux, N. Y., Rezende, T. M. B., Stashenko, P., Seki, M., Taubman, M. A., & Kawai, T. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03318.x · Cited by 89
Yamagami, W., Susumu, N., Tanaka, H., Hirasawa, A., Banno, K., Suzuki, N., Tsuda, H., Tsukazaki, K., & Aoki, D. (2011) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e31822c271f · Cited by 139
Comparative methodologies of regulatory T cell depletion in a murine melanoma model
Matsushita, N., Pilon‐Thomas, S., Martin, L. M., & Riker, A. I. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.01.012 · Cited by 97
“Tregs are considered to play an important role in maintaining self-tolerance (Sakaguchi, 2005).”
BackgroundBhowmick, S., Singh, A., Flavell, R. A., Clark, R. B., O’Rourke, J., & Cone, R. E. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0209107 · Cited by 86
“Because 6-OHDA injection caused an increase in the number of CD4 FoxP3 Tregs and these cells are known to suppress EAE [4, 8, 9, 35, 36], we explored the possibility of using 6-OHDA as a preventive measure against EAE.”
BackgroundInfluentialYang, H., Qiu, Q., Gao, B., Kong, S., Lin, Z., & Fang, D. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20140283 · Cited by 93
“However, because MHC-II–restricted expression of self-antigen is critical for FoxP3+ T reg cell development (Sakaguchi, 2005), the possibility that Hrd1 regulates DC MHC-II expression to modulate T reg cell development cannot be fully excluded.”
BackgroundThe Impact of Aging on Regulatory T-Cells
Fessler, J., Ficjan, A., Duftner, C., & Dejaco, C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00231 · Cited by 88
“The forkhead transcription factor FoxP3 was proposed as the most specific marker of Tregs as FoxP3 expression is essential for Treg development and function (9): Tregs were unable to develop in a mouse receiving FoxP3-deficient progenitor cells from another animal (10) and retroviral expression of FoxP3 in human and m…”
BackgroundSpäni, C., Suter, T., Derungs, R., Ferretti, M. T., Welt, T., Wirth, F., Gericke, C., Nitsch, R. M., & Kulic, L. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0251-x · Cited by 88
“Suppressive effects on both the adaptive and the innate arm of the immune system have been well documented for Tregs [66–68].”
BackgroundChivasso, C., Sarrand, J., Perret, J., Delporte, C., & Soyfoo, M. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020658 · Cited by 99
Zheng, Y., Manzotti, C. N., Burke, F., Dussably, L., Qureshi, O., Walker, L. S. K., & Sansom, D. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.1683 · Cited by 86
“O ver the last decade, CD4 CD25 regulatory T cells (Tregs)(3) have emerged as major regulators of immunity (1, 2).”
BackgroundHongo, D., Tang, X., Dutt, S., Nádor, R. G., & Strober, S. (2011) · Blood · doi:10.1182/blood-2011-08-371948 · Cited by 93
Inada, K., Shima, T., Ito, M., Ushijima, A., & Saito, S. (2014) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2014.09.053 · Cited by 93
“Regulatory T cells (Treg) play an important role in the induction and maintenance of tolerance (Sakaguchi et al., 1995; Sakaguchi, 2005).”
BackgroundNext-generation insights into regulatory T cells: expression profiling and FoxP3 occupancy in Human
Birzele, F., Fauti, T., Stahl, H., Lenter, M. C., Simon, E., Knebel, D., Weith, A., Hildebrandt, T., & Mennerich, D. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr444 · Cited by 84
Zaunders, J., Ip, S., Munier, C. M. L., Kaufmann, D., Suzuki, K., Brereton, C., Sasson, S. C., Seddiki, N., Koelsch, K. K., LANDAY, A. L., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00249-06 · Cited by 101
“CTLA-4 may be involved in T reg activity (61), and we previously observed that there was increased expression of CTLA-4 by polyclonally stimulated T cells during PHI (J.”
BackgroundKotner, J. S., & Tarleton, R. L. (2006) · Infection and Immunity · doi:10.1128/iai.01500-06 · Cited by 88
“Thus, we measured the expression of the Foxp3 gene (and its protein product, scurfin), which has been identified as the best-defined marker of natural Treg cells (36).”
BackgroundMethodThe role of regulatory T cells in alloantigen tolerance
Aluvihare, V. R., & Betz, A. G. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00408.x · Cited by 100
“The lack of Tregs in these mice suggests that they cannot utilize all the complementarity-determining regions utilized by conventional T cells (13), thus supporting the conclusion that Tregs are selected to”
BackgroundEcharti, A., Hecht, M., Büttner-Herold, M., Haderlein, M., Hartmann, A., Fietkau, R., & Distel, L. (2019) · Cancers · doi:10.3390/cancers11091398 · Cited by 87
“However, FoxP3 appears to be the best single marker for Treg [31].”
BackgroundAutoimmune thyroid diseases and Th17/Treg lymphocytes
Shao, S., Yu, X., & Shen, L. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.11.026 · Cited by 93
“In humans, CD4 CD25 T cells constitute 5–10% of peripheral CD4 T cells, and are involved in the pathogenesis of a number of autoimmune diseases [7].”
BackgroundTrendafilova, A. B., Moujir, L., Sousa, P. M. C., & Seca, A. M. L. (2020) · Foods · doi:10.3390/foods10010065 · Cited by 93
Kandulski, A., Wex, T., Kuester, D., Peitz, U., Gebert, I., Roessner, A., & Malfertheiner, P. (2008) · Helicobacter · doi:10.1111/j.1523-5378.2008.00612.x · Cited by 87
Yang, X., Yin, Y., & Wang, H. (2008) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.11.003 · Cited by 98
Kunzmann, V., Kimmel, B., Herrmann, T., Einsele, H., & Wilhelm, M. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02894.x · Cited by 87
Pathophysiology and management of primary immune thrombocytopenia
Kashiwagi, H., & Tomiyama, Y. (2013) · International Journal of Hematology · doi:10.1007/s12185-013-1370-4 · Cited by 87
Mailloux, A. W., Sugimori, C., Komrokji, R. S., Yang, L., Maciejewski, J. P., Sekeres, M. A., PAQUETTE, R. L., Loughran, T. P., List, A. F., & Epling‐Burnette, P. K. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200602 · Cited by 87
Expansion of FOXP3-positive CD4+CD25+ T cells associated with disease activity in atopic dermatitis
Ito, Y., Adachi, Y., Makino, T., Higashiyama, H., Fuchizawa, T., Shimizu, T., & Miyawaki, T. (2009) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60170-6 · Cited by 86
Huang, Y., Zozulya, A. L., Weidenfeller, C., Schwab, N., & Wiendl, H. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1008649 · Cited by 91
“CD4CD25 FoxP3-expressing nTreg were identified as key contributors in controlling autoreactive T cells and in maintaining peripheral tolerance to self and nonself antigens [ 2 , 3]. nTreg-mediated suppression requires direct cell‐cell interaction, or they act on Tresp through APC [4, 5]. Various phenotypically distinc…”
BackgroundImmunotherapy for Advanced Melanoma
Fang, L., Lonsdorf, A. S., & Hwang, S. T. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.101 · Cited by 93
“Tregs are crucial for maintenance of peripheral self-tolerance and suppression of antitumor immunity (Sakaguchi, 2005).”
BackgroundFoxp3+-Inducible Regulatory T Cells Suppress Endothelial Activation and Leukocyte Recruitment
Maganto-García, E., Bu, D.-X., Tarrio, M. L., Alcaide, P., Newton, G., Griffin, G. K., Croce, K. J., Luscinskas, F. W., Lichtman, A. H., & Grabie, N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003947 · Cited by 83
“R egulatory T cells (Treg) have a critical role in protecting against autoimmunity and regulating immune responses by suppressing T cell proliferation (1).”
BackgroundResultCharacterization of mouse CD4 T cell subsets defined by expression of KLRG1
Beyersdorf, N., Ding, X., Tietze, J. K., & Hanke, T. (2007) · European Journal of Immunology · doi:10.1002/eji.200737126 · Cited by 81
Tumor immune microenvironment modulation-based drug delivery strategies for cancer immunotherapy
Han, S., Huang, K., Gu, Z., & Wu, J. (2020) · Nanoscale · doi:10.1039/c9nr08086d · Cited by 93
IL-2 signaling and CD4+CD25+Foxp3+ regulatory T cells
Laurence, A. T. (2007) · Frontiers in bioscience · doi:10.2741/2773 · Cited by 85
“Although the precise mechanism by which these cells exert their immunosuppressive effects has not been elucidated it is known that they can potently inhibit effector T cell proliferation in vitro and regulate most types of T cell dependent immune response in vivo (27,28).”
BackgroundCancer therapy and vaccination
Aly, H. A. A. (2012) · Journal of Immunological Methods · doi:10.1016/j.jim.2012.05.014 · Cited by 96
CD4+CD25+Foxp3+ regulatory T cells suppress cardiac fibrosis in the hypertensive heart
Kanellakis, P., Dinh, T. N., Agrotis, A., & Bobik, A. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e328349c62d · Cited by 83
Ko, H.-J., Cho, M., Lee, S.-Y., Oh, H., Heo, Y., Moon, Y., Kang, C., Kwok, S., Ju, J. H., Park, S., et al. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.07.006 · Cited by 89
Osteoclast Activated FoxP3+ CD8+ T-Cells Suppress Bone Resorption in vitro
Buchwald, Z. S., Kiesel, J. R., DiPaolo, R., Pagadala, M. S., & Aurora, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038199 · Cited by 83
Fundamental mechanisms of host immune responses to infection
Azuma, M. (2006) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2006.00896.x · Cited by 99
Challenges and prospects of immunotherapy as cancer treatment
Rescigno, M., Avogadri, F., & Curigliano, G. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.07.003 · Cited by 100
Tumor Regulatory T Cells Potently Abrogate Antitumor Immunity
Liu, Z., Kim, J. H., Falo, L. D., & You, Z. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802664 · Cited by 90
“Thus, Foxp3 expression together with suppressor function (a cardinal feature of Treg) may be the best way to judge whether tumor CD4 CD25 T cells are actually Treg (14).”
BackgroundLow-dose radiation therapy of cancer: role of immune enhancement
Farooque, A., Mathur, R., Verma, A., Kaul, V., Bhatt, A. N., Adhikari, J. S., Afrin, F., Singh, S. P., & Dwarakanath, B. S. R. (2011) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.217 · Cited by 91
Phenotypic and functional characteristic of a newly identified CD8+Foxp3−CD103+ regulatory T cells
Liu, Y., Lan, Q., Lu, L., Chen, M., Xia, Z., Ma, J., Wang, J., Fan, H., Shen, Y., Ryffel, B., et al. (2013) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt026 · Cited by 86
“CD4+CD25+Foxp3+ regulatory/suppressor T (Treg) cells play a pivotal role in the maintenance of immune homeostasis and the prevention of autoimmunity (Sakaguchi, 2005).”
BackgroundPan, T. S., Liu, Y., Zhong, L. M., Shi, M. H., Duan, X. B., Wu, K., Yang, Q., Liu, C., Wei, J. Y., Ma, X. R., et al. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.1a1015-481rr · Cited by 84
“The important role of Tregs, which can suppress effector T cells in response to stimulation with fetalspecific antigens, has been well established in fetal immunotolerance [50] .”
BackgroundBae, M., Shin, H. S., See, H.-J., Jung, S. Y., Kwon, D., & Shon, D. (2016) · Scientific Reports · doi:10.1038/srep32225 · Cited by 86
Beyersdorf, N., Hanke, T., Kerkau, T., & Hünig, T. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.042564 · Cited by 98
Regulatory T cell responses: potential role in the control of atherosclerosis
Mallat, Z., Ait‐Oufella, H., & Tedgui, A. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000182532.11512.90 · Cited by 96
Ghoreishi, M., & Dutz, J. P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2635 · Cited by 84
“This subset of Treg cells has been shown to prevent autoimmune disease and to modulate host reactivity to viral and other neo-Ags (1, 2).”
Background
Metadata
- Authors
- Sakaguchi, S.
- Affiliations
- Kyoto University (JP)
- Corresponding author
- Sakaguchi, Shimon
- ORCID
- Sakaguchi, Shimon
- Venue
- Nature Immunology
- Published
- 2005-03-22
- Volume
- 6
- Issue
- 4
- Pages
- 345-352
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2004708987
- Cited by
- 2,669
- References
- 109
- Citations by year
- 2026: 12 · 2025: 33 · 2024: 39 · 2023: 54 · 2022: 59 · 2021: 68 · 2020: 68 · 2019: 84 · 2018: 83 · 2017: 92 · 2016: 98 · 2015: 113 · 2014: 127 · 2013: 148 · 2012: 169
- FWCI
- 22.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- Foxp3, regulatory T cells, CD4+CD25+ T cells, immune tolerance, self-tolerance, autoimmune disease, antitumor immunity, transplantation tolerance, antigen-specific T cell expansion, immunomodulation
- MeSH terms
- Animals, Antigens, Differentiation, Autoimmune Diseases, DNA-Binding Proteins, Humans, Lymphocyte Activation, Neoplasms, T-Lymphocytes, Thymus Gland, Transplantation Immunology, Receptors, Interleukin-2, Antigens, CD, CD4 Antigens, Self Tolerance, Forkhead Transcription Factors, CTLA-4 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.